Serveur d'exploration Tocilizumab

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Auvergne-Rhône-Alpes And NotAlexandre Belot

List of bibliographic references

Number of relevant bibliographic references: 91.
Ident.Authors (with country if any)Title
000060 Augustin Latourte [France] ; Hang-Korng Ea [France] ; Aline Frazier [France] ; Anne Blanchard [France] ; Frédéric Lioté [France] ; Hubert Marotte [France] ; Thomas Bardin [France] ; Pascal Richette [France]Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study.
000072 Rakesh Awasthi [États-Unis] ; Lida Pacaud [États-Unis] ; Edward Waldron [États-Unis] ; Constantine S. Tam [Australie] ; Ulrich J Ger [Autriche] ; Peter Borchmann [Allemagne] ; Samantha Jaglowski [États-Unis] ; Stephen Ronan Foley [Canada] ; Koen Van Besien [États-Unis] ; Nina D. Wagner-Johnston [États-Unis] ; Marie José Kersten [Pays-Bas] ; Stephen J. Schuster [États-Unis] ; Gilles Salles [France] ; Richard T. Maziarz [États-Unis] ; Özlem Anak [États-Unis] ; Christopher Del Corral [États-Unis] ; Jufen Chu [États-Unis] ; Irina Gershgorin [États-Unis] ; Iulian Pruteanu-Malinici [États-Unis] ; Abhijit Chakraborty [États-Unis] ; Karen Thudium Mueller [États-Unis] ; Edmund K. Waller [États-Unis]Tisagenlecleucel cellular kinetics, dose, and immunogenicity in relation to clinical factors in relapsed/refractory DLBCL
000074 Grégoire Ducoux [France] ; Arthur Guerber [France] ; Cécile-Audrey Durel [France] ; Bouchra Asli [France] ; Jehane Fadlallah [France] ; Arnaud Hot [France]Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients
000334 Amin Gasmi [France] ; Sadaf Noor [Pakistan] ; Torsak Tippairote [Thaïlande] ; Maryam Dadar [Iran] ; Alain Menzel [France] ; Geir Bj Rklund [Norvège]Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic
000385 Gaëlle Vial [France] ; Anaïs De Pouilly [France] ; Laetitia Scouppe [France] ; Bruno Pereira [France] ; Claire Daien [France] ; Cédric Lukas [France] ; Adeline Ruyssen-Witrand [France] ; Pascale Vergne-Salle [France] ; Christophe Richez [France] ; Anne Tournadre [France]Factors influencing the choice of biologic therapy following Rituximab in patients with rheumatoid arthritis: A retrospective study using propensity score.
000458 Kassandra Lanchais ; Frederic Capel ; Anne Tournadre [France]Could Omega 3 Fatty Acids Preserve Muscle Health in Rheumatoid Arthritis?
000600 François Rodrigues [France] ; Jean-Baptiste Philit [France] ; Irina Giurgea [France] ; Dany Anglicheau [France] ; Jean-Jacques Roux [France] ; Nadia Hoyeau [France] ; Gilles Grateau [France] ; Laurence Cuisset [France] ; Sophie Georgin-Lavialle [France]AA amyloidosis revealing mevalonate kinase deficiency: A report of 20 cases including two new French cases and a comprehensive review of literature.
000616 Kedra Joanna [France] ; Philippe Dieudé [France] ; Hubert Marotte [États-Unis] ; Alexandre Lafourcade [France] ; Emilie Ducourau [France] ; Thierry Schaeverbeke [France] ; Aleth Perdriger [France] ; Martin Soubrier [France] ; Jacques Morel [France] ; Arnaud Constantin [Royaume-Uni] ; Emmanuelle Dernis [France] ; Valérie Royant [France] ; Jean-Hugues Salmon [France] ; Thao Pham [France] ; Jacques-Eric Gottenberg [France] ; Edouard Pertuiset [France] ; Maxime Dougados [France] ; Valérie Devauchelle-Pensec [France] ; Philippe Gaudin [France] ; Gregoire Cormier [France] ; Philippe Goupille [France] ; Xavier Mariette [France] ; Francis Berenbaum [France] ; Didier Alcaix [France] ; Sid Ahmed Rouidi [France] ; Jean-Marie Berthelot [France] ; Agnès Monnier [France] ; Christine Piroth [France] ; Frederic Liote [France] ; Vincent Goeb [France] ; Cécile Gaujoux-Viala [France] ; Isabelle Chary Valckenaere [France] ; David Hajage [France] ; Florence Tubach [France] ; Bruno Fautrel [France]Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission
000A75 Marion Bossennec [France] ; Céline Rodriguez [France] ; Margaux Hubert [France] ; Anthony Di-Roio [France] ; Christelle Machon [France] ; Jérôme Guitton [France] ; Priscilla Battiston-Montagne [France] ; Mathilde Couturier ; Hubert Marotte [France] ; Christophe Caux [France] ; Fabienne Coury [France] ; Christine Ménétrier-Caux [France]Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado Production
000B49 Vincent Cottin [France] ; Kevin K. Brown [États-Unis]Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
000B69 Mélanie Rinaudo-Gaujous ; Vincent Blasco-Baque ; Pierre Miossec ; Philippe Gaudin ; Pierre Farge ; Xavier Roblin ; Thierry Thomas [France] ; Stephane Paul ; Hubert Marotte [France]Infliximab Induced a Dissociated Response of Severe Periodontal Biomarkers in Rheumatoid Arthritis Patients
000E47 Jacques-Eric Gottenberg [France] ; Jacques Morel [France] ; Elodie Perrodeau [France] ; Thomas Bardin [France] ; Bernard Combe [France] ; Maxime Dougados [France] ; Rene-Marc Flipo [France] ; Alain Saraux [France] ; Thierry Schaeverbeke [France] ; Jean Sibilia [France] ; Martin Soubrier [France] ; Olivier Vittecoq [France] ; Gabriel Baron [France] ; Arnaud Constantin [France] ; Philippe Ravaud [France] ; Xavier Mariette [France]Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study
000F04 Benjamin Castagné [France] ; Marie Viprey [France] ; Julie Martin [France] ; Anne-Marie Schott [France] ; Michel Cucherat [France] ; Martin Soubrier [France]Cardiovascular safety of tocilizumab: A systematic review and network meta-analysis
001011 Cécile Luxembourger [France] ; Adeline Ruyssen-Witrand [France] ; Chayma Ladhari [France] ; Cécile Rittore [France] ; Yannick Degboe [France] ; Jean-Francis Maillefert [France] ; Philippe Gaudin [France] ; Hubert Marotte [France] ; Daniel Wendling [France] ; Christian Jorgensen [France] ; Alain Cantagrel [France] ; Arnaud Constantin [France] ; Delphine Nigon [France] ; Isabelle Touitou [France] ; Jacques-Eric Gottenberg [France] ; Yves-Marie Pers [France]A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients.
001019 Théo Willeman [France] ; Jean-François Jourdil [France] ; Elodie Gautier-Veyret [France] ; Bruno Bonaz [France] ; Françoise Stanke-Labesque [France]A multiplex liquid chromatography tandem mass spectrometry method for the quantification of seven therapeutic monoclonal antibodies: Application for adalimumab therapeutic drug monitoring in patients with Crohn's disease.
001075 E. Diwo [France] ; P. Sève [France] ; S. Trad [France] ; P. Bielefeld [France] ; D. Sène [France] ; S. Abad [France] ; A. Brézin [France] ; P. Quartier [France] ; I. Koné Paut [France] ; M. Weber [France] ; C. Chiquet [France] ; M H Errera [France] ; J. Sellam [France] ; P. Cacoub [France] ; G. Kaplanski [France] ; L. Kodjikian [France] ; B. Bodaghi [France] ; D. Saadoun [France][Therapeutic strategy for the treatment of non-infectious uveitis proposed by an expert panel].
001085 A. Pierrot [France] ; C. Combe [France] ; M. Lepelley [France] ; M. Brucker [France] ; E. Constant [France][Berger's disease associated to an adalimumab-treated rheumatoid arthritis].
001220 Adamah Amouzougan [France] ; Delphine Dénarié [France] ; Hubert Marotte [France] ; Xavier Roblin [France] ; Thierry Thomas [France]Rheumatoid arthritis treated with tocilizumab in two patients with complicated chronic liver disease with portal hypertension.
001233 Daniel Abramowicz [Belgique] ; Rainer Oberbauer [Autriche] ; Uwe Heemann [Allemagne] ; Ondrej Viklicky [République tchèque] ; Licia Peruzzi [Italie] ; Christophe Mariat [France] ; Marta Crespo [Espagne] ; Klemens Budde [Allemagne] ; Gabriel C. Oniscu [Royaume-Uni]Recent advances in kidney transplantation: a viewpoint from the Descartes advisory board*
001292 Clément Lahaye [France] ; Zuzana Tatar [France] ; Jean-Jacques Dubost [France] ; Anne Tournadre [France] ; Martin Soubrier [France]Management of inflammatory rheumatic conditions in the elderly
001314 Marco Bigoni [Italie] ; Marco Turati [Italie, France] ; Giovanni Zatti [Italie] ; Marta Gandolla [Italie] ; Paola Sacerdote [Italie] ; Massimiliano Piatti [Italie] ; Alberto Castelnuovo [Italie] ; Luca Rigamonti [Italie] ; Daniele Munegato [Italie] ; Silvia Franchi [Italie] ; Nicola Portinaro [Italie] ; Alessandra Pedrocchi [Italie] ; Robert J. Omeljaniuk [Canada] ; Vittorio Locatelli [Italie] ; Antonio Torsello [Italie]Intra-Articular Cytokine Levels in Adolescent Patients after Anterior Cruciate Ligament Tear
001363 Martin Peju [France] ; Alban Deroux [France] ; Hervé Pelloux [France] ; Laurence Bouillet [France] ; Olivier Epaulard [France]Hypereosinophilia: Biological investigations and etiologies in a French metropolitan university hospital, and proposed approach for diagnostic evaluation
001388 Arsene Mekinian [France] ; Mathieu Resche-Rigon [France] ; Cloé Comarmond [France] ; Alessandra Soriano ; Joel Constans [France] ; Laurent Alric [France] ; Patrick Jego [France] ; Florian Busato [France] ; Matthieu Cabon [France] ; Robin Dhote [France] ; Lazaro Estibaliz [France] ; Isabelle Koné-Paut [France] ; Cédric Landron [France] ; Christian Lavigne [France] ; Bertrand Lioger [France] ; Martin Michaud [France] ; Marc Ruivard [France] ; Karim Sacre [France] ; Jacques Eric Gottenberg [France] ; Francis Gaches [France] ; Tiphaine Goulenok [France] ; Carlo Salvarani ; Patrice Cacoub [France] ; Olivier Fain [France] ; David Saadoun [France]Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients.
001398 Guillaume Moulis [France] ; Grégory Pugnet [France] ; Nathalie Costedoat-Chalumeau [France] ; Alexis Mathian [France] ; Gaëlle Leroux [France] ; Jonathan Boutémy [France] ; Olivier Espitia [France] ; Laurence Bouillet [France] ; Sabine Berthier [France] ; Jean-Baptiste Gaultier [France] ; Pierre-Yves Jeandel [France] ; Amadou Konaté [France] ; Arsène Mékinian [France] ; Elisabeth Solau-Gervais [France] ; Benjamin Terrier [France] ; Daniel Wendling [France] ; Fanny Andry [France] ; Camille Garnier [France] ; Pascal Cathébras [France] ; Laurent Arnaud [France] ; Aurore Palmaro [France] ; Patrice Cacoub [France] ; Zahir Amoura [France] ; Jean-Charles Piette [France] ; Philippe Arlet [France] ; Maryse Lapeyre-Mestre [France] ; Laurent Sailler [France]Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study.
001568 Fabrice Cognasse [France] ; Olivier Garraud [France] ; Hubert Marotte [France]Unlike tocilizumab, etanercept slightly increases experimental thrombin-induced aggregation in healthy individuals.
001592 Nihal Martis [France] ; David Chirio [France] ; Viviane Queyrel-Moranne [France] ; Marie-Christine Zenut [France] ; Fanny Rocher [France] ; Jean-Gabriel Fuzibet [France]Tocilizumab-induced hypofibrinogenemia: A report of 7 cases.
001633 Jean-Jacques Dubost [France] ; Bruno Pereira [France] ; Anne Tournadre [France] ; Zuzana Tatar [France] ; Marion Couderc [France] ; Martin Soubrier [France]The changing face of septic arthritis complicating rheumatoid arthritis in the era of biotherapies. Retrospective single-center study over 35years.
001704 Romain Gastaldi [France] ; Aurélie Sicaud ; Philippe Gaudin ; Athan BailletPulmonary Pasteurellosis in a Patient Treated With Tocilizumab for Rheumatoid Arthritis.
001736 L. Méry-Bossard [France] ; K. Bagny [France] ; G. Chaby [France] ; A. Khemis [France] ; F. Maccari [France] ; H. Marotte [France] ; J L Perrot [France] ; Z. Reguiai [France] ; M L Sigal [France] ; M. Avenel-Audran [France] ; T. Boyé [France] ; A. Grasland [France] ; J. Gillard [France] ; D. Jullien [France] ; E. Toussirot [France]New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases.
001737 Taghreed Hirz [France] ; Eva-Laure Matera [France] ; Kamel Chettab [France] ; Lars Petter Jordheim [France] ; Doriane Mathé [France] ; Anne Evesque [France] ; Justine Esmenjaud [France] ; Gilles Salles [France] ; Charles Dumontet [France]Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding
001769 Ricardo P. Garay [France] ; Carlos A. Zarate [États-Unis] ; Thomas Charpeaud [France] ; Leslie Citrome [États-Unis] ; Christoph U. Correll [États-Unis] ; Ahcène Hameg [France] ; Pierre-Michel Llorca [France]Investigational drugs in recent clinical trials for treatment-resistant depression
001884 Arsene Mekinian [France] ; Guillaume Dervin [France] ; Nathanael Lapidus [France] ; Jean-Emmanuel Kahn [France] ; Louis Terriou [France] ; Eric Liozon [France] ; Eric Grignano [France] ; Jean-Charles Piette [France] ; Odile Beyne Rauzy [France] ; Vincent Grobost [France] ; Pascal Godmer [France] ; Jerome Gillard [France] ; Julien Rossignol [France] ; David Launay [France] ; Achille Aouba [France] ; Thierry Cardon [France] ; Laurence Bouillet [France] ; Jonathan Broner [France] ; Julien Vinit [France] ; Lionel Ades [France] ; Fabrice Carrat [France] ; Clementine Salvado [France] ; Eric Toussirot [France] ; Mathilde Versini [France] ; Nathalie Costedoat-Chalumeau [France] ; Jean Baptiste Fraison [France] ; Philippe Guilpain [France] ; Pierre Fenaux [France] ; Olivier Fain [France]Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: French multicenter retrospective study of 29 patients.
001948 A. Deroux [France] ; F. Andry [France] ; L. Bouillet [France][Macrophage activation syndrome secondary to tocilizumab: Myth or reality?].
001963 X. Palard-Novello [France] ; S. Querellou [France] ; M. Gouillou [France] ; A. Saraux [France] ; T. Marhadour [France] ; F. Garrigues [France] ; R. Abgral [France] ; P Y Salaün [France] ; V. Devauchelle-Pensec [France]Value of (18)F-FDG PET/CT for therapeutic assessment of patients with polymyalgia rheumatica receiving tocilizumab as first-line treatment.
001988 Alban Deroux [France] ; Chistophe Chiquet [France] ; Laurence Bouillet [France]Tocilizumab in severe and refractory Behcet's disease: Four cases and literature review.
001A77 Éric Toussirot [France] ; Antoine Martin [France] ; Martin Soubrier [France] ; Serge Redeker [France] ; Alexis Régent [France]Rapid and Sustained Response to Tocilizumab in Patients with Polymyalgia Rheumatica Resistant or Intolerant to Glucocorticoids: A Multicenter Open-label Study.
001A89 P O Barros ; T. Cassano ; J. Hygino ; T B Ferreira ; N. Centurião ; T M Kasahara ; R M Andrade ; U C Linhares ; A F B. Andrade [Brésil] ; C C F. Vasconcelos ; R. Alvarenga ; R. Marignier [France] ; C A M. BentoPrediction of disease severity in neuromyelitis optica by the levels of interleukin (IL)-6 produced during remission phase.
001A98 Mathieu Gerfaud-Valentin [France] ; Vincent Cottin [France] ; Yvan Jamilloux [France] ; Arnaud Hot [France] ; Agathe Gaillard-Coadon [France] ; Isabelle Durieu [France] ; Christiane Broussolle [France] ; Jean Iwaz [France] ; Pascal Sève [France]Parenchymal lung involvement in adult-onset Still disease
001B14 Cindy Mourgues [France] ; Cecile Henquell [France] ; Zuzana Tatar [France] ; Bruno Pereira [France] ; Cinthya Nourisson [France] ; Anne Tournadre [France] ; Martin Soubrier [France] ; Marion Couderc [France]Monitoring of Epstein-Barr virus (EBV)/cytomegalovirus (CMV)/varicella-zoster virus (VZV) load in patients receiving tocilizumab for rheumatoid arthritis.
001B58 Coline Faivre [France] ; Axel Patrice Villani [France] ; François Aubin [France] ; Dan Lipsker [France] ; Martine Bottaro [France] ; Jean-David Cohen [France] ; François Durupt [France] ; Géraldine Jeudy [France] ; Emilie Sbidian [France] ; Eric Toussirot [France] ; Valérie Badot [Belgique] ; Sébastien Barbarot [France] ; Sébastien Debarbieux [France] ; Emmanuel Delaporte [France] ; Guetty Goegebeur [France] ; Jacques Morel [France] ; Aude Nassif [France] ; Gérard Duru [France] ; Denis Jullien [France]Hidradenitis suppurativa (HS): An unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases.
001C69 Amandine Beaumel [France] ; Olivier Muis-Pistor [France] ; Jacques-Guy Tebib [France] ; Fabienne Coury [France]Antisynthetase syndrome treated with tocilizumab.
001C76 C. Giraud [France] ; Z. Tatar [France] ; M. Soubrier [France]Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis
001E30 E. Feurer [France] ; P. Bielefeld [France] ; D. Saadoun [France] ; P. Sève [France][Biologics in uveitis].
001E34 Valérie Devauchelle-Pensec [France] ; Jacques-Eric Gottenberg [France] ; Sandrine Jousse-Joulin [France] ; Jean-Marie Berthelot [France] ; Aleth Perdriger [France] ; Eric Hachulla [France] ; Pierre Yves Hatron [France] ; Xavier Puechal [France] ; Véronique Le Guern [France] ; Jean Sibilia [France] ; Laurent Chiche [France] ; Vincent Goeb [France] ; Olivier Vittecoq [France] ; Claire Larroche [France] ; Anne Laure Fauchais [France] ; Gilles Hayem [France] ; Jacques Morel [France] ; Charles Zarnitsky [France] ; Jean Jacques Dubost [France] ; Philippe Dieudé [France] ; Jacques Olivier Pers [France] ; Divi Cornec [France] ; Raphaele Seror [France] ; Xavier Mariette [France] ; Emmanuel Nowak [France] ; Alain Saraux [France]Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren’s Syndrome?
001E79 Karine Briot [France] ; Stéphanie Rouanet [France] ; Thierry Schaeverbeke [France] ; Fabien Etchepare [France] ; Philippe Gaudin [France] ; Aleth Perdriger [France] ; Muriel Vray [France] ; Ghislaine Steinberg [France] ; Christian Roux [France]The effect of tocilizumab on bone mineral density, serum levels of Dickkopf-1 and bone remodeling markers in patients with rheumatoid arthritis.
001F71 Emmanuel Forestier [France] ; Jean-Louis Pasquali [France]Long-term safety of tocilizumab treatment on chronic active hepatitis C in a patient with adult onset Still's disease.
001F76 V. Margelidon-Cozzolino [France] ; K. Chbini [Maroc] ; N. Freymond [France] ; G. Devouassoux [France] ; A. Belaaouaj [France] ; Y. Pacheco [France]La BPCO : une maladie qui commence précocement
002040 Yves-Marie Pers [France] ; Roxane Schaub [France] ; Elodie Constant [France] ; Joseph Lambert [France] ; Marie Godfrin-Valnet [France] ; Clémentine Fortunet [France] ; Waafa Bourichi [France] ; Béatrice Pallot Prades [France] ; Daniel Wendling [France] ; Philippe Gaudin [France] ; Christian Jorgensen [France] ; Jean-Francis Maillefert [France] ; Hubert Marotte [France]Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis.
002067 Ciara L. Freeman [Royaume-Uni] ; Franck Morschhauser [France] ; Laurie Sehn [Canada] ; Mark Dixon [Royaume-Uni] ; Richard Houghton [Royaume-Uni] ; Thierry Lamy [France] ; Günter Fingerle-Rowson [Suisse] ; Elisabeth Wassner-Fritsch [Suisse] ; John G. Gribben [Royaume-Uni] ; Michael Hallek [Allemagne] ; Gilles Salles [France] ; Guillaume Cartron [France]Cytokine release in patients with CLL treated with obinutuzumab and possible relationship with infusion-related reactions
002268 E. Weber [France] ; J-B Gaultier [France] ; S. Paul [France] ; I. Guichard [France] ; E. Monard [France] ; P. Cathébras [France][Sustained response with tocilizumab in a case of refractory relapsing polychondritis].
002279 F. Pasquet [France] ; M. Pavic [France] ; J. Ninet [France] ; A. Hot [France][Autoimmune diseases and cancers. Part I: cancers complicating autoimmune diseases and their treatment].
002291 Yvan Jamilloux [France, Suisse] ; Mathieu Gerfaud-Valentin [France] ; Thomas Henry [France] ; Pascal Sève [France]Treatment of adult-onset Still’s disease: a review
002455 Anne C. Bay-Jensen [Danemark] ; Adam Platt [Royaume-Uni] ; Inger Byrjalsen [Danemark] ; Philippe Vergnoud [France] ; Claus Christiansen [Danemark] ; Morten A. Karsdal [Danemark]Effect of tocilizumab combined with methotrexate on circulating biomarkers of synovium, cartilage, and bone in the LITHE study.
002470 Delphine Dénarié [France] ; Elodie Constant [France] ; Thierry Thomas [France] ; Hubert Marotte [France]Could Biomarkers of Bone, Cartilage or Synovium Turnover Be Used for Relapse Prediction in Rheumatoid Arthritis Patients?
002510 Mathieu Gerfaud-Valentin [France] ; Yvan Jamilloux [Suisse] ; Jean Iwaz [France] ; Pascal Sève [France]Adult-onset Still's disease.
002621 E. Weber [France] ; J.-B. Gaultier [France] ; S. Paul [France] ; I. Guichard [France] ; E. Monard [France] ; P. Cathebras [France]Réponse prolongée après traitement par tocilizumab d'une polychondrite atrophiante
002625 F. Pasquet [France] ; M. Pavic [France] ; J. Ninet [France] ; A. Hot [France]Maladies auto-immunes et cancers. Première partie: cancers au cours des maladies auto-immunes et de leur traitement
002695 Justine Bacchetta [États-Unis, France] ; Joshua J. Zaritsky [États-Unis] ; Jessica L. Sea ; Rene F. Chun ; Thomas S. Lisse ; Kathryn Zavala ; Anjali Nayak [États-Unis] ; Katherine Wesseling-Perry [États-Unis] ; Mark Westerman [États-Unis] ; Bruce W. Hollis [États-Unis] ; Isidro B. Salusky [États-Unis] ; Martin HewisonSuppression of Iron-Regulatory Hepcidin by Vitamin D
002774 Sylvain Mathieu [France] ; Marion Couderc [France] ; Baptiste Glace [France] ; Bruno Pereira [France] ; Anne Tournadre [France] ; Jean-Jacques Dubost [France] ; Martin Soubrier [France]Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis
002839 Maxime Dougados [France] ; Valérie Devauchelle-Pensec [France] ; Jean François Ferlet [France] ; Sandrine Jousse-Joulin [France] ; Maria-Antonietta D'Agostino [France] ; Marina Backhaus [Allemagne] ; Jacques Bentin [Belgique] ; Gérard Chalès [France] ; Isabelle Chary-Valckenaere [France] ; Philip Conaghan [Royaume-Uni] ; Richard J. Wakefield [Royaume-Uni] ; Frédéric Etcheparre [France] ; Philippe Gaudin [France] ; Walter Grassi [Italie] ; Désirée Van Der Heijde [Pays-Bas] ; Xavier Mariette [France] ; Esperanza Naredo [Espagne] ; Marcin Szkudlarek [Danemark]The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound
002910 Y. Van Eijk-Hustings [Pays-Bas] ; B. Buss [Allemagne] ; F. Fayet [France] ; A. Moretti [Italie] ; M. Ndosi [Royaume-Uni] ; S. Ryan [Royaume-Uni] ; C. Savel [France] ; M. Scholte-Voshaar [Pays-Bas] ; J. De La Torre-Aboki [Espagne] ; A. Van Tubergen [Pays-Bas]THU0598 Dissemination and Evaluation of the Eular Recommendations for the Role of the Nurse in the Management of Chronic Inflammatory Arthritis
002A25 Y.-M. Pers [France] ; C. Fortunet ; E. Constant ; J. Lambert [France] ; A. Mazouyes [France] ; M. Valnet [France] ; H. Marotte ; P. Gaudin [France] ; D. Wendling [France] ; J.-F. Maillefert ; C. Jorgensen [France]THU0126 Multicenter retrospective study: Response to tocilizumab in clinical practice is not influenced by the number of previous biotherapy or by association with a DMARD
002D60 B. Kayser [Suisse] ; S. Verges [France]Hypoxia, energy balance and obesity: from pathophysiological mechanisms to new treatment strategies
002E50 M. Kostine ; T. Barnetche ; E. Ardouin ; M. Joly [France] ; E. Rabois [France] ; B. Glace [France] ; T. Schaeverbeke ; C. RichezFRI0192 Is early neutropenia associated with clinical response in patients receiving tocilizumab in rheumatoid arthritis?
002F10 I. Castrejon [États-Unis] ; T. Pincus [États-Unis] ; M. Soubrier [France] ; Y. C. Lin [États-Unis] ; M. Dougados [France]FRI0077 Relative efficiencies of joint counts and laboratory tests are no higher than patient-reported measures to document superior results in the guepard tight-control versus espoir routine care cohorts
003196 L. Rossi-Semerano ; B. Fautrel [France] ; D. Wendling ; E. Hachulla ; A. Meyer [France] ; S. Ottaviani [France] ; R. Dhote ; C. Galeotti ; M. Fouillet-Desjonquères [France] ; O. Richer ; I. Touitou [France] ; I. Kone-PautAB0322 Survey of off-label anti-il1 treatments in france: two years results
003218 M. Couderc [France] ; S. Mathieu [France] ; M. Soubrier [France]AB0310 Predictive factors for the response to rituximab in rheumatoid arthritis: Results from a french university hospital
003390 Martin Soubrier [France] ; Zuzana Tatar [France] ; Marion Couderc [France] ; Sylvain Mathieu [France] ; Jean-Jacques Dubost [France]Rheumatoid Arthritis in the Elderly in the Era of Tight Control
003401 Roland Chapurlat [France] ; Deborah Gensburger [France] ; Juan Jimenez-Andrade [États-Unis] ; Joseph Ghilardi [États-Unis] ; Marilyn Kelly [États-Unis] ; Patrick Mantyh [États-Unis]Pathophysiology and medical treatment of pain in fibrous dysplasia of bone
003477 Roland D. Chapurlat [France] ; Deborah Gensburger [France] ; Juan M. Jimenez-Andrade [États-Unis] ; Joseph R. Ghilardi [États-Unis] ; Marilyn Kelly [États-Unis] ; Patrick Mantyh [États-Unis]Pathophysiology and medical treatment of pain in fibrous dysplasia of bone
003496 Fernando Kemta Lekpa [France] ; Cécile Poulain [France] ; Daniel Wendling [France] ; Martin Soubrier [France] ; Michel De Bandt [France] ; Jean Marie Berthelot [France] ; Philippe Gaudin [France] ; Eric Toussirot [France] ; Philippe Goupille [France] ; Thao Pham [France] ; Jérémie Sellam [France] ; Rémy Bruckert [France] ; Muriel Paul [France] ; Valérie Farrenq [France] ; Pascal Claudepierre [France]Is IL-6 an appropriate target to treat spondyloarthritis patients refractory to anti-TNF therapy? a multicentre retrospective observational study
003560 J E Gottenberg [France] ; P. Ravaud [France] ; A. Cantagrel [France] ; B. Combe [France] ; R M Flipo [France] ; T. Schaeverbeke [France] ; E. Houvenagel [France] ; P. Gaudin [France] ; D. Loeuille [France] ; S. Rist [France] ; M. Dougados [France] ; J. Sibilia [France] ; X. Le Loët [France] ; C. Marcelli [France] ; T. Bardin [France] ; I. Pane [France] ; G. Baron [France] ; X. Mariette [France]Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry
003614 Pierre Miossec [France] ; Jay K. Kolls [États-Unis]Targeting IL-17 and TH17 cells in chronic inflammation
003658 A. Finet [France] ; M. Amini-Adle [France] ; B. Balme [France] ; F. Colson [France] ; L. Thomas [France]Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: cause or coincidence?
003713 Maxime Samson [France] ; Sylvain Audia [France] ; Nona Janikashvili [France] ; Marion Ciudad [France] ; Malika Trad [France] ; Jennifer Fraszczak [France] ; Paul Ornetti [France] ; Jean-Francis Maillefert [France] ; Pierre Miossec [France] ; Bernard Bonnotte [France]Brief Report: Inhibition of interleukin‐6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis
003838 Maxime Samson [France] ; Sylvain Audia [France] ; Nona Janikashvili [France] ; Marion Ciudad [France] ; Malika Trad [France] ; Jennifer Fraszczak [France] ; Paul Ornetti [France] ; Jean-Francis Maillefert [France] ; Pierre Miossec [France] ; Bernard Bonnotte [France]Inhibition of Interleukin-6 Function Corrects Th17/Treg Cell Imbalance in Patients With Rheumatoid Arthritis
003962 Morten A. Karsdal [Danemark] ; Thasia Woodworth [États-Unis] ; Kim Henriksen [Danemark] ; Walter P. Maksymowych [Canada] ; Harry Genant [France] ; Philippe Vergnaud [France] ; Claus Christiansen [Danemark] ; Tanja Schubert [France] ; Per Qvist [Danemark] ; Georg Schett [Allemagne] ; Adam Platt [Royaume-Uni] ; Anne-Christine Bay-Jensen [Danemark]Biochemical markers of ongoing joint damage in rheumatoid arthritis - current and future applications, limitations and opportunities
003A26 Pierre Quartier [France] ; Florence Allantaz [États-Unis] ; Rolando Cimaz [France] ; Pascal Pillet [France] ; Claude Messiaen [France] ; Christophe Bardin [France] ; Xavier Bossuyt [Belgique] ; Anne Boutten [France] ; Jacques Bienvenu [France] ; Agnes Duquesne [France] ; Olivier Richer [France] ; Damien Chaussabel [États-Unis] ; Agnes Mogenet [France] ; Jacques Banchereau [États-Unis] ; Jean-Marc Treluyer [France] ; Paul Landais [France] ; Virginia Pascual [États-Unis]A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
003B14 E. Merlin [France] ; L. Berthomieu [France] ; C. Dauphin [France] ; J. L. Stéphan [France]Cardiac Tamponade in a Child With Systemic-Onset Juvenile Idiopathic Arthritis: Dramatic Improvement After Interleukin-1 Blockade by Anakinra
003B68 Xavier Puechal [France] ; Michel De Bandt [France] ; Jean-Marie Berthelot [France] ; Maxime Breban [France] ; Jean-Jacques Dubost [France] ; Olivier Fain [France] ; Jean-Emmanuel Kahn [France] ; Laurence Lequen [France] ; Maïté Longy-Boursier [France] ; Aleth Perdriger [France] ; Thierry Schaeverbeke [France] ; Eric Toussirot [France] ; Jean Sibilia [France]Tocilizumab in Refractory Adult Still's Disease
003B74 C. B. Confavreux [France] ; R. D. Chapurlat [France]Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis
003C42 Javeed Iqbal ; Dennis D. Weisenburger ; Timothy C. Greiner ; Julie M. Vose ; Timothy Mckeithan ; Can Kucuk ; Huimin Geng ; Karen Deffenbacher ; Lynette Smith ; Karen Dybkaer [Danemark] ; Shigeo Nakamura [Japon] ; Masao Seto [Japon] ; Jan Delabie ; Francoise Berger [France] ; Florence Loong [République populaire de Chine] ; Wing Y. Au [République populaire de Chine] ; Young-Hyeh Ko [Corée du Sud] ; Ivy Sng [Singapour] ; James Olen Armitage ; Wing C. ChanMolecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
003C55 Jun Hashimoto [Japon] ; Patrick Garnero [France] ; Désirée Van Der Heijde [Pays-Bas] ; Nobuyuki Miyasaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Shinichi Kawai [Japon] ; Tsutomu Takeuchi [Japon] ; Hideki Yoshikawa [Japon] ; Norihiro Nishimoto [Japon]Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study
003D43 C. B. Confavreux [France] ; R. D. Chapurlat [France]Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis
003D44 Alain Beck [France] ; Thierry Wurch [France] ; Christian Bailly [France] ; Nathalie Corvaia [France]Strategies and challenges for the next generation of therapeutic antibodies
003E50 Zuzana Kubandova [France] ; Sylvain Mathieu [France] ; Claire Pourtier [France] ; Martin Soubrier [France]Zona grave dans la polyarthrite rhumatoïde au cours d'un traitement par anti-IL6
003E69 Patrick Garnero [France] ; Elizabeth Thompson [Royaume-Uni] ; Thasia Woodworth [Royaume-Uni] ; Josef S. Smolen [Autriche]Rapid and Sustained Improvement in Bone and Cartilage Turnover Markers With the Anti-Interleukin-6 Receptor Inhibitor Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Substudy of the Multicenter Double-Blind, Placebo-Controlled Trial of Tocilizumab in Inadequate Responders to Methotrexate Alone
003F12 Angélique Gougelet [France] ; Adeline Mansuy [France] ; Jean-Yves Blay [France, Belgique] ; Laurent Alberti [France] ; Claudine Vermot-Desroches [France]Lymphoma and Myeloma Cell Resistance to Cytotoxic Agents and Ionizing Radiations Is Not Affected by Exposure to Anti–IL-6 Antibody
003F66 Alain Beck ; Elsa Wagner-Rousset [France] ; Thierry Wurch [France] ; Nathalie Corvaia [France]Anticorps thérapeutiques et dérivés : une palette de structures pour une pléthore d’indications
004100 Angélique Gougelet [France] ; Adeline Mansuy [France] ; Jean-Yves Blay [France]De l’eau au moulin de thérapies ciblant l’interleukine-6 dans les tumeurs épithéliales
004408 Benoit Ben Said [France] ; Mathieu Gerfaud-Valentin [France] ; Pascal Seve [France]Fatal DRESS syndrome under tocilizumab treatment for seronegative polyarthritis.

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021